Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins v 3 and v 5 in patients with advanced solid tumours

Author： Eskens F.A.L.M.   Dumez H.   Hoekstra R.   Perschl A.   Brindley C.   Bottcher S.   Wynendaele W.   Drevs J.   Verweij J.   van Oosterom A.T.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.7, 2003-05, pp. : 917-926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)

By Terret C.   Zanetta S.   Roche H.   Schellens J.H.M.   Faber M.N.   Wanders J.   Ravic M.   Droz J.P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1097-1104

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer

By Souza Paul   Liauw Winston   Links Matthew   Pirabhahar Saiyini   Kelly Graham   Howes Laurence  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 427-433

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

By Trocòniz Iñaki   Garrido María   Segura Cristina   Cendrós Josep-María   Principe Paola   Peraire Concepción   Obach Rosendo  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 727-735

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours

By Androulakis N.   Kouroussis C.   Mavroudis D.   Kakolyris S.   Souglakos J.   Agelaki S.   Kalbakis K.   Malas K.   Pallis A.   Samonis G.   Georgoulias V.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1992-1997

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours

By de Jonge M.J.A.   Verweij J.   van der Gaast A.   Valota O.   Mora O.   Planting A.S.T.   Mantel M.A.   Bosch S.V.D.   Lechuga M.J.   Fiorentini F.   Hess D.   Sessa C.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2407-2415

Elsevier

Access to resources Recommend Favorite